论文部分内容阅读
目的:探讨α-细辛脑注射液雾化吸入辅助治疗新生儿肺炎的临床疗效。方法:选择我院在2013年1月-2013年12月诊断为新生儿肺炎的患儿100例,将患儿随机分为两组,对照组应用吸氧、抗生素以及对症支持治疗,治疗组在对照组的基础上联合应用α-细辛脑注射液雾化吸入辅助治疗,治疗一疗程后分析两组患儿临床疗效,住院时间,不良反应等方面。结果:治疗组的临床疗效优于对照组,住院时间短于对照组,两组相比均有显著性差异(P<0.05),具有统计学意义,两组的不良反应相比差异不显著性(P>0.05),无统计学意义。结论:α-细辛脑治疗新生儿肺炎时,临床疗效好,病程短,不良反应少,值得临床推广。
Objective: To investigate the clinical efficacy of α-Asarone Injection in the treatment of neonatal pneumonia. Methods: A total of 100 children with neonatal pneumonia were selected from January 2013 to December 2013 in our hospital. The children were randomly divided into two groups. In the control group, oxygenation, antibiotics and symptomatic supportive therapy were used. Control group based on the combination of α-Asarone injection of nebulized inhalation therapy, treatment of a course of treatment of children with clinical efficacy, length of stay, adverse reactions and so on. Results: The clinical efficacy of the treatment group was better than that of the control group, and the length of stay in the treatment group was shorter than that of the control group. There was significant difference between the two groups (P <0.05), with statistical significance. There was no significant difference in adverse reactions between the two groups (P> 0.05), no statistical significance. Conclusion: Aspirin treatment of neonatal pneumonia, clinical efficacy, short course, fewer adverse reactions, worthy of clinical promotion.